Skip to main content
Maria Rodriguez, MD, Oncology, San Antonio, TX

MariaA.RodriguezMD

Oncology San Antonio, TX

Physician

Dr. Rodriguez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rodriguez's full profile

Already have an account?

  • Office

    5439 Ray Ellison Blvd
    San Antonio, TX 78242

Summary

  • Dr. Maria Rodriguez is a pediatrician in San Antonio, TX.

Education & Training

  • University of Arizona College of Medicine-Tucson
    University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1983 - 1986
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 1979 - 1982
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 1979

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2026
  • GA State Medical License
    GA State Medical License 2023 - 2026
  • TX State Medical License
    TX State Medical License 2013 - 2026
  • LA State Medical License
    LA State Medical License 2023 - 2025
  • MS State Medical License
    MS State Medical License 2023 - 2025
  • OK State Medical License
    OK State Medical License 2020 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • Fellow (FACP) American College of Physicians, 2001

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Results of a Phase II Study of Obinutuzumab in Combination with Lenalidomide in Previously Untreated, High Tumor Burden Follicular Lymphoma (FL)
    Maria Alma Rodriguez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A Phase II Trial of Nivolumab and Ibrutinib for Patients with Relapsed or Refractory Central Nervous System Lymphoma
    Maria Alma Rodriguez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Radiation Therapy Can be an Effective Bridging Strategy Prior to Axicabtagene Ciloleucel Therapy for Relapsed/Refractory Large B-Cell LymphomaRadiation Therapy Can be ...
    Maria Alma Rodriguez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Analysis of financial sustainability of survivorship clinics led by advanced practice providers. 
    2019 ASCO Annual Meeting - 6/1/2019

Professional Memberships